SEARCH RESULTS FOR:

Ricardo Méndez Pastrana

DIRECTOR GENERAL, PROMAPLAST
Chemical distributor PromaPlast details the milestones achieved on its 25th anniversary.

Marco Mastrodonato

FOUNDER AND CEO, BMG PHARMA
Italy Life Sciences 2021
BMG explains the potential of its modified hyaluronic acid technology.

Omar Alessandrini

CEO, Biomedical Pharma
Italy Life Sciences 2021
Biomedical Pharma explains the huge scope for its photocatalytic cleaning products.

Laurent Piat

MANAGING DIRECTOR, VEOLIA GHANA
MACIG West Africa 2021-2022
Veolia designs and provides solutions for water, waste and energy management.

Bernard Kaninda

REGIONAL DIRECTOR AFRICA, MAXAM
MACIG West Africa 2021-2022
Maxam describes its services and the current opportunities in West Africa.

Deon de Kock

PRESIDENT, SUB-SAHARAN AFRICA, MIDDLE EAST & SOUTH ASIA, FLSMIDTH
MACIG Southern Africa 2021 - Digital Interactive
FLSmidth is an international supplier of sustainable solutions and services to the global cement and mining industries.

Mxolisi Mgojo, Nombasa Tsengwa & Sakkie Swanepoel

CEO; CEO-DESIGNATE AND MANAGING DIRECTOR OF MINERALS & GROUP MANAGER MARKETING, EXXARO RESOURCES
MACIG Southern Africa 2021 - Digital Interactive
Exxaro considers the role of coal as South Africa moves towards green energies.

Stefan Lepecki

CEO, BRASKEM IDESA
Latin America Petrochemicals and Chemicals 2021 - Digital Interactive
Braskem Idesa updates GBR on key developments over the past year.

Jan Krueder

CEO, QUÍMICA ANASTACIO
Latin America Petrochemicals and Chemicals 2021 - Digital Interactive
Química Anastacio explains its strategy during the pandemic and how the company has managed increasing demand for chemical products.

Jody Kuzenko

PRESIDENT & CEO, TOREX GOLD RESOURCES
"From the beginning, we understood how important a desired workplace culture is to safely achieve our goals, particularly in a jurisdiction as socially complex as Guerrero, Mexico."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS